NICOLE KREBS: Open Payments
NPI 1861064735 · SUNBURY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,151 in 114 payments from 18 companies in 2025. Trend: 2023 $1,839 · 2024 $2,247 · 2025 $2,151
Food & beverage: $2,151
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $387 |
| AstraZeneca Pharmaceuticals LP | 14 | $338 |
| PFIZER INC. | 17 | $257 |
| Novo Nordisk Inc | 14 | $246 |
| Lilly USA, LLC | 11 | $210 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $132 |
| Amgen Inc. | 6 | $104 |
| Dexcom, Inc. | 4 | $87 |
| Otsuka America Pharmaceutical, Inc. | 4 | $68 |
| CeQur Corporation | 1 | $60 |
Products named: VRAYLAR, AIRSUPRA, ELIQUIS, CAPLYTA, MOUNJARO, JARDIANCE, FARXIGA, NURTEC ODT.
Industry payments across PA — which companies pay providers there.
